Entero Healthcare Solutions Ltd Share Price Today

Mutual Fund Holder	Aug 26 Shares held	Sep 26 Shares held
Invesco India Contra Fund - Regular Plan - Growth	13.00 Lac	11.92 Lac (8.31%)
HDFC Balanced Advantage Fund - Growth	-	11.83 Lac (100%)
Bank of India Flexi Cap Fund - Regular Plan - Growth	3.97 Lac	4.10 Lac (3.29%)
ICICI Prudential Healthcare Fund - Growth	4.77 Lac	2.98 Lac (37.46%)
Edelweiss Small Cap Fund - Regular Plan - Growth	-	2.82 Lac (100%)

Ashish Kumar

20 Sep • 9:39 PM · SEBI-Registered Analyst

HDFC Mutual Fund has acquired a 3.2% stake in Entero

HDFC Mutual Fund has acquired a 3.2% stake in

ENTERO

Entero Healthcare Solutions through a block deal on the National Stock Exchange (NSE). The asset management company bought roughly 13.90 lakh shares, amounting to approximately ₹235.6 crore, at a price of ₹1,695 per share. The seller in the transaction was the Prasid Uno Family Trust, which has been systematically trimming its holdings in the healthcare distribution company. As of June 2026, the trust held a 10.45% stake (about 45.50 lakh shares) in Entero Healthcare. Following recent rounds of share sales—including this latest block deal—the trust has divested a cumulative 7.39% stake over the quarter, reflecting a major reduction in its shareholding as the stock has experienced sharp upward momentum.

Palak Jain

20 Sep • 1:45 AM · SEBI-Registered Analyst

**HDFC Mutual Fund Just Bought ₹236 Crore Of Entero**

**HDFC Mutual Fund Just Bought ₹236 Crore Of Entero** This caught my attention because it wasn't a normal market transaction.

HDFCAMC

HDFC Mutual Fund bought around 13.9 lakh shares of Entero Healthcare Solutions through a block deal. The transaction was worth approximately ₹236 crore. Now, whenever I see a large institutional transaction, I don't immediately treat it as a “buy signal.” There can be several reasons behind a block deal. But it is definitely something worth understanding. Who bought? Who sold? At what price? How large was the transaction compared with the company's total equity? And most importantly, what does it actually change for the business? In this case, the shares were acquired from Prasid Uno Family Trust. The transaction represented around 3.19% of Entero's equity. That's meaningful enough to make the news interesting. But here's the bigger lesson. Institutional buying can create attention around a stock. It can also influence short-term sentiment. But one transaction doesn't tell us the entire investment story. You still need to study earnings, valuations, growth and business fundamentals. So when you see: “Mutual Fund buys ₹236 crore worth of shares” Don't simply think: “Big investor bought it, so I should buy it.” Instead ask: **What exactly happened? And why did it happen?** That's a much better way to read stock-market news. 📊 #EnteroHealthcare #StockMarket #Investing #MutualFunds #IndianStockMarket

Ankush

19 Sep • 1:16 PM · SEBI-Registered Analyst

HDFC MF BUYS 3.19% STAKE IN ENTERO HEALTHCARE SOLUTIONS

HDFCAMC

HDFC Mutual Fund acquired a 3.19% stake in Entero Healthcare Solutions from Prasid Uno Family Trust through open-market transactions on September 18, even as shares of the healthcare products distribution company gained 3.94% to close at ₹1,732.30 on the NSE. According to block deal data, HDFC Mutual Fund purchased 13.9 lakh shares of Entero Healthcare Solutions, representing 3.19% of the company’s paid-up equity, for ₹235.6 crore. The shares were bought at ₹1,695 apiece. Public shareholder Surbhi Singh, through Prasid Uno Family Trust, was the seller in the transaction. The trust serves as the family investment vehicle of Medlife co-founder Tushar Kumar. Following Friday’s transaction, the trust has sold 32.18 lakh shares, or a 7.39% stake, in Entero Healthcare Solutions during the September quarter. This compares with its 10.45% holding, equivalent to 45.5 lakh shares, as of June 2026. Meanwhile, Boston-based State Street Global Advisors, through the SPDR Portfolio Emerging Markets ETF, sold 37.32 lakh shares, representing a 0.97% stake, in pharmaceutical company Sigachi Industries for ₹11.13 crore. The shares were sold at ₹29.83 apiece. Sigachi Industries ended 0.92% higher at ₹29.60 on Friday after retreating sharply from an intraday high of ₹32.15, with robust trading volumes recorded during the session.

InvestAce Capital

25 Aug • 3:13 PM · SEBI-Registered Analyst

Entero Healthcare Builds Scale in Pharma Distribution

Entero Healthcare Solutions (

ENTERO

) is building a large healthcare distribution and supply-chain platform, connecting pharmaceutical manufacturers with hospitals, pharmacies and other healthcare providers. The company is now attracting institutional attention. 3P Investment Managers, owned by Prashant Jain, acquired a 2.5% stake in Entero through open-market transactions on August 24, 2026, after which the stock gained around 15% over two sessions. The more interesting part is the underlying business model. Entero operates across pharmaceutical distribution and healthcare supply chains, where scale can improve purchasing, inventory management and distribution efficiency. Its Q1 FY27 performance also showed continued business expansion, making the combination of operating scale and increasing investor interest worth tracking. The stock is therefore interesting not simply because a well-known investor bought it, but because the investment brings attention to a relatively under-discussed part of India's healthcare ecosystem: the infrastructure that moves medicines from manufacturers to the end customer.

SASI KUMAR SEBI RA

25 Aug • 7:53 AM · SEBI-Registered Analyst

Pre Market Report & Global Cues | 25 August, 2026

Global cues are slightly weak this morning. US markets closed mixed. While the Dow managed a small gain, both S&P and Nasdaq ended lower, showing pressure in tech. US bond yields have moved up to around 4.72%, which is something to keep an eye on. Asian markets are also mostly under pressure. South Korea (-2.1%) is seeing sharp weakness, and other markets like Japan, Taiwan and China are also in the red. Reflecting this, Gift Nifty is indicating around a 50–70 point gap-down, suggesting a soft start for our market. Brent crude continues to stay elevated near $92.7, and the rupee is around 95.74, still at weak levels. Along with this, India’s 10Y yield is near 6.87% and 30Y at 7.49%, showing some rise in bond yields. These factors together need close tracking. There will be good stock-specific action today. Welspun Corp will remain in focus after a strong ₹17,200 crore order pipeline. RailTel is also active with a ₹164 crore order, while JBM Auto may see interest on reports of a ₹2,850 crore investment in its EV business. Metal stocks like Hindustan Copper and Tata Steel could stay active with support from global prices. Yes Bank is in focus after RBI approval for SMBC to acquire up to 24.99% stake, and Skipper continues to see traction with an order book above ₹9,200 crore. On the weaker side, sugar stocks may remain under pressure after policy changes. Swiggy-related names and Entero Healthcare could see volatility due to ongoing selling and block deals. SBI Life and Bajaj Finance may also stay under pressure along with the broader financial space. For today’s session: Expect a slightly weak to flat opening based on Gift Nifty. With crude high, rupee weak and yields moving up, the market may remain range-bound. Watch how Nifty behaves near 24,000 support and whether it can move back towards 24,300 on any bounce.

Sunil Kotak

8 Aug • 1:40 PM · SEBI-Registered Analyst

Q1FY27 Quarterly Result Announced for Entero Healthcare Solutions Ltd.

SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826

ENTERO

Q1FY27 Quarterly Result Announced for Entero Healthcare Solutions Ltd. Healthcare Services company Entero Healthcare Solutions announced Q1FY27 results Consolidated Financial Highlights: Revenue from Operations for Q1FY27 stood at Rs 19,404.95 million, registering a QoQ growth of 1.60% from Rs 19,099.27 million in Q4FY26 and a significant YoY increase of 38.23% from Rs 14,038.19 million in Q1FY26. Total Income for the quarter was Rs 19,435.02 million, up 1.54% QoQ from Rs 19,139.35 million in Q4FY26 and 37.87% YoY from Rs 14,096.44 million in Q1FY26. Profit before exceptional items and tax for Q1FY27 was Rs 671.20 million, showing a QoQ increase of 15.83% from Rs 579.47 million in Q4FY26 and a YoY growth of 84.58% compared to Rs 363.63 million in Q1FY26. Net Profit for the period was reported at Rs 520.51 million in Q1FY27, up 15.34% QoQ from Rs 451.28 million in Q4FY26 and up 72.17% YoY from Rs 302.32 million in Q1FY26. Total Comprehensive Income for Q1FY27 reached Rs 519.21 million, compared to Rs 448.38 million in Q4FY26 and Rs 303.54 million in Q1FY26. Basic Earnings Per Share (EPS) for Q1FY27 was Rs 8.77, compared to Rs 6.44 in Q4FY26 and Rs 6.39 in Q1FY26. All this is for information This is not a buy/sell recommendation. Thank you, Technofunda24

Entero Healthcare Solutions Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Entero Healthcare Solutions Ltd. 👋

Expert Opinions

Frequently Asked Questions

What is the share price of Entero Healthcare Solutions Ltd.?

What is the market cap of Entero Healthcare Solutions Ltd.?

Should I buy Entero Healthcare Solutions Ltd. stock now?

What is the 52 week high and low of Entero Healthcare Solutions Ltd.?

Is the Entero Healthcare Solutions Ltd. stock good to buy?

Is Entero Healthcare Solutions Ltd. a good buy for the long term?

Is Entero Healthcare Solutions Ltd. overvalued or undervalued?

What is the PE and PB ratio of Entero Healthcare Solutions Ltd.?